Silicon Investor (SI) -- The First Internet Community

STOCKTALK

We've detected that you're using an ad content blocking browser plug-in or feature. Ads provide a critical source of revenue to the continued operation of Silicon Investor. We ask that you disable ad blocking while on Silicon Investor in the best interests of our community. If you are not using an ad blocker but are still receiving this message, make sure your browser's tracking protection is set to the 'standard' level.

Biotech / Medical : DYGN - Dynagen -- Ignore unavailable to you. Want to Upgrade?

To: Jeff Konrad who wrote (400)	1/9/1999 1:00:00 PM
From: Tadsamillionaire	Read Replies (1) \| Respond to of 444

Only from the rumor off raging bull.com that stated new financing was in place. And the fact that new patents had been given to DYGN for HIV treatment. In my opinion the 10k looks no different than most pennystock, turnaround companies. It's a gamble. Apparently someone other than the few investors who read this thread think so also.Thats the only way that I can explain the volume on Friday. Just my humble opinion. I will stay Long on DYGN. Especially after buying in this time last year and riding it to $1.56 per share from .156cents.